Clinical trialNCT00761722CompletedPhase 1Interventional

Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma

SponsorCelgeneEnrollment31Acute Myeloid LeukemiaLeukemia, Myelomonocytic, ChronicLymphomaMultiple MyelomaMyelodysplastic Syndromes

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to compare the amount of drug that gets into the bloodstream between different tablets taken by mouth and an injection under the skin.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Barry Skikne, MD, FACP, FCP (SA)
Celgene Corporation
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

California Cancer Care Inc
Greenbrae, California, United States
Main Cancer Centers of Florida, P.A.
Ocoee, Florida, United States
Indiana University School of Medicine
Indianapolis, Indiana, United States
University of Kansas Medical Center
Kansas City, Kansas, United States
Washington University School of Medicine
St Louis, Missouri, United States
Northwest Cancer Specialists, P.C.
Albuquerque, New Mexico, United States
Willamette Valley Cancer Institute
Springfield, Oregon, United States
University of Texas- Md Anderson
Houston, Texas, United States
Hematology and Oncology Assoc. of South Texas
San Antonio, Texas, United States
Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
Yakima Valley Memorial Hospital/ North Star Lodge
Yakima, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Azacitidine →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 12 Aug 2008
Primary completion: 6 Apr 2016
Completion: 7 Apr 2016
Last update posted: 8 Nov 2019
Registered enrollment: 31
Registry id: NCT00761722

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.